Clinical Trial Update: Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxaban [Phase 3]

View source ↗

Summary

A Phase 3 pilot study evaluating rivaroxaban for cancer-associated thrombosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasm
• Venous Thromboembolism

Drugs mentioned

• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Neoplasm, Venous Thromboembolism | Phase 3 | Status: COMPLETED